CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


04-November-2014
Introducing the latest stable-labeled antifungal internal standard from Cerilliant, (±)-Voriconazole-D3.

(±)-Voriconazole-D3, 1.0 mg/mL V-036
1.0 mg/mL in Methanol

A stable-labeled internal standard suitable for quantification of voriconazole levels in blood, serum, or plasma by HPLC or LC-MS/MS for applications such as therapeutic drug monitoring or clinical and diagnostic testing. Voriconazole, sold under the trade name Vfend®, is a triazole antifungal drug prescribed for treatment of serious, invasive fungal infections.

Coming soon, Cerilliant will introduce stable-labeled internal standards of Itraconazole-D4, Posaconazole-D4, and Ketoconazole-D4.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn